These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15732862)

  • 1. Impact of an anti-inflammatory therapy and its withdrawal on the progression of experimental periodontitis in rats.
    Gurgel BC; Duarte PM; Nociti FH; Sallum EA; Casati MZ; Sallum AW; de Toledo S
    J Periodontol; 2004 Dec; 75(12):1613-8. PubMed ID: 15732862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective cyclooxygenase-2 inhibition prevents alveolar bone loss in experimental periodontitis in rats.
    Bezerra MM; de Lima V; Alencar VB; Vieira IB; Brito GA; Ribeiro RA; Rocha FA
    J Periodontol; 2000 Jun; 71(6):1009-14. PubMed ID: 10914805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of selective cyclooxygenase-2 inhibition on the development of ligature-induced periodontitis in rats.
    Holzhausen M; Rossa Júnior C; Marcantonio Júnior E; Nassar PO; Spolidório DM; Spolidório LC
    J Periodontol; 2002 Sep; 73(9):1030-6. PubMed ID: 12296588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COX-2 inhibition decreases VEGF expression and alveolar bone loss during the progression of experimental periodontitis in rats.
    Oliveira TM; Sakai VT; Machado MA; Dionísio TJ; Cestari TM; Taga R; Amaral SL; Santos CF
    J Periodontol; 2008 Jun; 79(6):1062-9. PubMed ID: 18533784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of nicotine on the bone loss rate in ligature-induced periodontitis. A histometric study in rats.
    Nociti FH; Nogueira-Filho GR; Primo MT; Machado MA; Tramontina VA; Barros SP; Sallum EA
    J Periodontol; 2000 Sep; 71(9):1460-4. PubMed ID: 11022776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective cyclooxygenase-2 inhibition prevents bone resorption.
    Nassar CA; Nassar PO; Nassar PM; Spolidorio LC
    Braz Oral Res; 2005; 19(1):36-40. PubMed ID: 16229354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective COX-2 inhibitor reduces bone healing in bone defects.
    Gurgel BC; Ribeiro FV; Silva MA; Nociti FH; Sallum AW; Sallum EA; Toledo Sd; Casati MZ
    Braz Oral Res; 2005; 19(4):312-6. PubMed ID: 16491262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of etoricoxib, a selective inhibitor of cyclooxygenase-2, in experimental periodontitis in rats.
    Holzhausen M; Spolidorio DM; Muscará MN; Hebling J; Spolidorio LC
    J Periodontal Res; 2005 Jun; 40(3):208-11. PubMed ID: 15853965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gingival crevicular fluid matrix metalloproteinase-8 levels following adjunctive use of meloxicam and initial phase of periodontal therapy.
    Buduneli N; Vardar S; Atilla G; Sorsa T; Luoto H; Baylas H
    J Periodontol; 2002 Jan; 73(1):103-9. PubMed ID: 11846190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smoking cessation may present a positive impact on mandibular bone quality and periodontitis-related bone loss: a study in rats.
    César-Neto JB; Benatti BB; Neto FH; Sallum AW; Sallum EA; Nociti FH
    J Periodontol; 2005 Apr; 76(4):520-5. PubMed ID: 15857091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Administration of high doses of caffeine increases alveolar bone loss in ligature-induced periodontitis in rats.
    Bezerra JP; da Silva LR; de Alvarenga Lemos VA; Duarte PM; Bastos MF
    J Periodontol; 2008 Dec; 79(12):2356-60. PubMed ID: 19053927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppressant therapy and bone loss in ligature-induced periodontitis--a study in rats.
    Gonçalves PF; Nogueira Filho Gda R; Sallum EA; Sallum AW; Nociti Júnior FH
    Pesqui Odontol Bras; 2003; 17(1):46-50. PubMed ID: 12908059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alendronate may protect against increased periodontitis-related bone loss in estrogen-deficient rats.
    Duarte PM; de Assis DR; Casati MZ; Sallum AW; Sallum EA; Nociti FH
    J Periodontol; 2004 Sep; 75(9):1196-202. PubMed ID: 15515333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ischaemic colitis in a patient taking meloxicam.
    Garcia B; Ramaholimihaso F; Diebold MD; Cadiot G; Thiéfin G
    Lancet; 2001 Mar; 357(9257):690. PubMed ID: 11247558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rheumatic disease therapy without regret. Meloxicam dosage safety].
    MMW Fortschr Med; 2002 Nov; 144(46):66-7. PubMed ID: 12534086
    [No Abstract]   [Full Text] [Related]  

  • 16. Nicotine effects on alveolar bone changes induced by occlusal trauma: a histometric study in rats.
    Nogueira-Filho GR; Fróes Neto EB; Casati MZ; Reis SR; Tunes RS; Tunes UR; Sallum EA; Nociti FH; Sallum AW
    J Periodontol; 2004 Mar; 75(3):348-52. PubMed ID: 15088871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histometric evaluation of the effect of nicotine administration on periodontal breakdown: an in vivo study.
    Nociti FH; Nogueira-Filho GR; Tramontina VA; Machado MA; Barros SP; Sallum EA; Sallum AW
    J Periodontal Res; 2001 Dec; 36(6):361-6. PubMed ID: 11762871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of baicalin on ligature-induced periodontitis in rats.
    Cai X; Li C; Du G; Cao Z
    J Periodontal Res; 2008 Feb; 43(1):14-21. PubMed ID: 18230102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers.
    Brzozowski T; Konturek PC; Konturek SJ; Sliwowski Z; Pajdo R; Drozdowicz D; Ptak A; Hahn EG
    Microsc Res Tech; 2001 Jun; 53(5):343-53. PubMed ID: 11376495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The renal protective effect of selective cyclooxygenase-2 inhibitor on obstructive nephropathy].
    Zuo Y; Ma J; Gu Y; Yang H; Lin S
    Zhonghua Nei Ke Za Zhi; 2002 Dec; 41(12):825-8. PubMed ID: 12654237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.